# Lowe Syndrome: Simplified Activity Frequency Table for Cost Modeling

## Annual Resource Utilization by Age Group and Service Category

| Age Group | Ophthalmology Visits | Nephrology Visits | Neurology Visits | Primary Care | Hospitalizations | PT/OT/ST Sessions | Major Surgeries |
|-----------|---------------------|-------------------|------------------|--------------|------------------|-------------------|-----------------|
| 0-1 year | 2-4 (under anesthesia) | 4 | 2-4 | 12+ | 1-3 | 100-150 | 1-2 (cataract, possible glaucoma) |
| 1-5 years | 2-4 | 2-4 | 4-8* | 4-6 | 1-3 | 100-150 | 0-2 (glaucoma, strabismus, hernia) |
| 5-13 years | 1-2 | 2-4 | 2-6* | 2-4 | 0.5-2 | 50-100 | 0-1 |
| 13-18 years | 1-2 | 4-12** | 2-4* | 2-4 | 1-3 | 25-75 | 0-1 (possible VNS, vascular access) |
| 18-30 years | 1-2 | 12-52+*** | 2-4* | 2-4 | 1-3 | Varies | 1-2 (transplant, access) |
| 30-50+ years | 1-2 | 12-52+*** | 2-4* | 2-4 | 1-3+ | Varies | Variable |

*If seizures present; otherwise 0-2 visits/year
**Increases as CKD progresses
***If on dialysis: 156 sessions/year + monthly labs; if transplant: frequent first year then less

## Key Interventions by Age with Approximate Prevalence

### Birth to 1 Year
| Intervention | Prevalence | Frequency | Notes |
|--------------|-----------|-----------|-------|
| Cataract surgery | 100% | Once (bilateral) | Within first weeks of life |
| Glaucoma diagnosis/surgery | ~50% | Variable | May need multiple procedures |
| Kidney function monitoring | 100% | Every 3 months | Transitions to treatment by ~1 year |
| Medication initiation (kidney) | ~95% | Daily (lifelong) | Multiple medications |
| Eye exams under anesthesia | 100% | 2-4/year | Through early childhood |
| EEG | Variable | As needed | If seizures suspected |
| Genetic testing | 100% | Once | At diagnosis |

### 1-5 Years
| Intervention | Prevalence | Frequency | Notes |
|--------------|-----------|-----------|-------|
| Seizure diagnosis/management | ~45% | Varies | 31% first diagnosed ages 1-5 |
| Strabismus surgery | Common | 1-2 procedures | Pre-op patching therapy |
| Hernia repair | Common | Once per hernia | Inguinal/umbilical |
| Cryptorchidism repair | Males | Once if needed | Before age 1 ideally |
| Intensive therapies | 100% | 2-3x/week each | PT, OT, ST |
| Kidney medication adjustment | 100% | Ongoing | Regular lab monitoring |

### 5-13 Years
| Intervention | Prevalence | Frequency | Notes |
|--------------|-----------|-----------|-------|
| Behavioral interventions | Common | Variable | Peak ages 8-13 |
| Nephrocalcinosis monitoring | ~40% | Annual imaging | Kidney stones |
| Scoliosis screening | Increasing | Annual | Begins in teenage years |
| Dental care | 100% | 2-4 visits/year | Increased frequency may be needed |
| Educational services | 100% | Daily | Special education/IEP |

### 13-18 Years
| Intervention | Prevalence | Frequency | Notes |
|--------------|-----------|-----------|-------|
| Corneal degeneration management | ~50% | Ongoing | By teenage years |
| CKD Stage 3-4 management | Increasing | More frequent visits | Pre-dialysis planning |
| Anemia management (EPO) | ~45% by this age | Weekly to monthly | As CKD progresses |
| Vagus nerve stimulator | Rare | Once if done | Refractory epilepsy |
| Transition planning | 100% | Ongoing | To adult services |

### 18-30+ Years
| Intervention | Prevalence | Frequency | Notes |
|--------------|-----------|-----------|-------|
| Dialysis (hemodialysis) | Many by age 30-40 | 3x/week | ~4 hours per session |
| Dialysis (peritoneal) | Alternative | Daily | Home-based |
| Kidney transplant | Limited data | Once | 2 cases in 2008 survey |
| Vascular access surgery | If on hemodialysis | Initially + revisions | AV fistula/graft |
| Residential care | Increasing | Ongoing | As needed for support |

## Chronic Kidney Disease Progression Model

| CKD Stage | Description | GFR (ml/min/1.73mÂ²) | Expected Management | Estimated % Reaching by Age 30* |
|-----------|-------------|---------------------|---------------------|--------------------------------|
| Stage 1 | Kidney damage, normal GFR | >90 | Monitoring, medications | 100% (all have kidney damage) |
| Stage 2 | Mild decrease in GFR | 60-89 | Monitoring, medications | ~95% |
| Stage 3 | Moderate decrease | 30-59 | More frequent monitoring | ~60-70% |
| Stage 4 | Severe decrease | 15-29 | Pre-dialysis/transplant planning | ~40-50% |
| Stage 5 (ESRD) | Kidney failure | <15 | Dialysis, transplant, or comfort care | ~30-40% |

*Estimates based on natural history; actual percentages need validation from registry data

## Medication Burden by Age

| Age Group | Average Daily Medications | Key Categories |
|-----------|---------------------------|----------------|
| 0-1 year | 2-4 | Kidney supplements (start ~1 year) |
| 1-5 years | 3-6 | Kidney supplements, AEDs if seizures |
| 5-13 years | 3-7 | Kidney supplements, AEDs, other supports |
| 13-18 years | 4-10 | Kidney supplements, AEDs, anemia treatment, +others as CKD progresses |
| 18+ years | 5-15+ | All above + dialysis-related or immunosuppressants if transplant |

## Therapy Intensity by Age

| Age Group | PT Sessions/Week | OT Sessions/Week | ST Sessions/Week | Total Annual Sessions |
|-----------|------------------|------------------|------------------|----------------------|
| 0-2 years | 2-3 | 2-3 | 1-2 | 150-200 |
| 2-5 years | 2-3 | 2-3 | 1-2 | 150-200 |
| 5-13 years | 1-2 | 1-2 | 0-1 | 50-150 |
| 13-18 years | 0-1 | 0-1 | 0-1 | 0-100 |
| 18+ years | As needed | As needed | Rare | Variable |

## Expected Surgeries Over Lifetime (Cumulative)

| Surgery Type | Expected Number | Typical Age Range | Notes |
|--------------|-----------------|-------------------|-------|
| Cataract removal | 2 (bilateral) | Birth to 3 months | Universal |
| Glaucoma procedures | 0-6+ | Birth to 20 years | ~50% affected, may need multiple |
| Strabismus correction | 0-3 | 2-10 years | Common, may recur |
| Hernia repairs | 0-3 | Throughout life | Increased risk due to hypotonia |
| Cryptorchidism repair | 0-2 (males) | Before age 1-2 | If present |
| Vascular access (if dialysis) | 1-5+ | 15-40+ years | Initial placement + revisions |
| Kidney transplant | 0-1 | 20-40+ years | Limited data, but option |
| Corneal transplant | 0-2 | 15-30+ years | Rare, last resort |
| Vagus nerve stimulator | 0-1 | 10-25 years | Rare, refractory seizures |
| Enucleation | 0-1 | Variable | Very rare |
| Orthopedic procedures | 0-2 | Variable | Fractures, possible scoliosis surgery |

## Cost Modeling Notes

### High-Cost Events (One-Time or Infrequent)
1. **Cataract surgery** (bilateral) - Early infancy
2. **Glaucoma surgeries** - Multiple possible over 0-20 years
3. **Kidney transplant** - Single event, high initial cost + lifelong immunosuppression
4. **Major complications** - Status epilepticus, acute kidney injury, etc.

### High-Cost Ongoing Services
1. **Hemodialysis** - 156 sessions/year (dominant cost in ESRD phase)
2. **Multiple specialist visits** - Accumulates significantly
3. **Intensive therapies** - Early years (ages 0-5)
4. **Medications** - Lifelong, multiple daily
5. **Special education services** - Ages 2-21

### Considerations for QALY/Quality of Life
1. **Visual impairment** - Progressive, impacts all daily activities
2. **Cognitive disability** - Wide range (borderline-normal to severe)
3. **Physical disability** - Hypotonia, motor delays, wheelchairs often needed
4. **Seizures** - If present, impacts safety and independence
5. **Dialysis burden** - Significant impact on quality of life if reached
6. **Behavior challenges** - Peak ages 8-13, may extend to adulthood

### Caregiver Burden (Indirect Costs)
1. **24/7 supervision** - Often lifelong
2. **Complex medication management** - Daily
3. **Multiple appointments** - Time off work
4. **Therapy transportation** - Frequent in early years
5. **Dialysis transportation** - 3x/week if not home-based
6. **School advocacy** - IEP meetings, coordination

---

*This simplified format is designed for easier input into cost modeling tools. Each cell should be populated with specific cost data from relevant sources (claims data, fee schedules, literature).*
